Sanofi and Regeneron’s Dupixent scores 3rd FDA approval in sinusitis with nasal polyps

Dupixent won FDA approval Wednesday to treat adult patients with chronic rhinosinusitis with nasal polyps. (Sanofi) Sanofi and Regeneron’s Dupixent has been charging ahead since its initial approval in moderate-to-severe atopic dermatitis, later picking up a follow-up nod in moderate-to-severe asthma. Wednesday, the drug scored FDA approval for its third use: to treat adults with chronic… Read More »

AI technology comes under fire from critics in Senate hearing

With the adoption of artificial intelligence by industries including healthcare, critics contend that there are inherent problems with AI which have the potential to negatively impact the lives of Americans. Rashida Richardson, director of policy research at New York University’s AI Now Institute, told a Senate subcommittee on Tuesday that the use of recommendation algorithms,… Read More »